Evidence map›Paper›PMID 32300970›Full record

ArticleEuropean radiology2020

Differentiation of predominant subtypes of lung adenocarcinoma using a quantitative radiomics approach on CT.

Sohee Park, Sang Min Lee, Han Na Noh, Hye Jeon Hwang, Seonok Kim, Kyung-Hyun Do, Joon Beom Seo

Abstract read
PubMed Publisher
In one paragraph

Article in European radiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Intratumoral and peritumoral radiomics model for the preoperative prediction of cribriform component in invasive lung adenocarcinoma: a multicenter study.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Impacts ofMolecular imaging and radionuclide therapy · 2024
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Sohee ParkDepartment of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center, 88 Olympic-ro 43 Gil, Songpa-gu, Seoul, 138-736, South Korea.
Sang Min LeeDepartment of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center, 88 Olympic-ro 43 Gil, Songpa-gu, Seoul, 138-736, South Korea. sangmin.lee.md@gmail.com.
Han Na NohDepartment of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center, 88 Olympic-ro 43 Gil, Songpa-gu, Seoul, 138-736, South Korea.
Hye Jeon HwangDepartment of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center, 88 Olympic-ro 43 Gil, Songpa-gu, Seoul, 138-736, South Korea.
Seonok KimDepartment of Medical Statistics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
Kyung-Hyun DoDepartment of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center, 88 Olympic-ro 43 Gil, Songpa-gu, Seoul, 138-736, South Korea.
Joon Beom SeoDepartment of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center, 88 Olympic-ro 43 Gil, Songpa-gu, Seoul, 138-736, South Korea.

Funding

Ministry of Science, ICT and Future Planning NRF-2016R1A2B1016355
6 · The paper itself

Abstract

objectivesTo develop a model for differentiating the predominant subtype-based prognostic groups of lung adenocarcinoma using CT radiomic features, and to validate its performance in comparison with radiologists' assessments.

methodsA total of 993 patients presenting with invasive lung adenocarcinoma between March 2010 and June 2016 were identified. Predominant histologic subtypes were categorized into three groups according to their prognosis (group 0: lepidic; group 1: acinar/papillary; group 2: solid/micropapillary). Seven hundred eighteen radiomic features were extracted from segmented lung cancers on contrast-enhanced CT. A model-development set was formed from the images of 893 patients, while 100 image sets were reserved for testing. A least absolute shrinkage and selection operator method was used for feature selection. Performance of the radiomic model was evaluated using receiver operating characteristic curve analysis, and accuracy on the test set was compared with that of three radiologists with varying experiences (6, 7, and 19 years in chest CT).

resultsOur model differentiated the three groups with areas under the curve (AUCs) of 0.892 and 0.895 on the development and test sets, respectively. In pairwise discrimination, the AUC was highest for group 0 vs. 2 (0.984). The accuracy of the model on the test set was higher than the averaged accuracy of the three radiologists without statistical significance (73.0% vs. 61.7%, p = 0.059). For group 2, the model achieved higher PPV than the observers (85.7% vs. 35.0-48.4%).

conclusionsPredominant subtype-based prognostic groups of lung adenocarcinoma were classified by a CT-based radiomic model with comparable performance to radiologists. KEY POINTS: • A CT-based radiomic model differentiated three prognosis-based subtype groups of lung adenocarcinoma with areas under the curve (AUCs) of 0.892 and 0.895 on development and test sets, respectively. • The CT-based radiomic model showed near perfect discrimination between group 0 and group 2 (AUCs, 0.984-1.000). • The accuracy of the CT-based radiomic model was comparable to the averaged accuracy of the three radiologists with 6, 7, and 19 years of clinical experience in chest CT (73.0% vs. 61.7%, p = 0.059), achieving a higher positive predictive value for group 2 than the observers (85.7% vs. 35.0-48.4%).

Indexed as

Adenocarcinoma of LungAdultAgedAged, 80 and overFemaleHumansLung NeoplasmsMaleMiddle AgedNeoplasm StagingPrognosisROC CurveTomography, X-Ray ComputedAdenocarcinoma of lungAlgorithmsComputed, X-ray computedHistological type of neoplasm

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.